
Stay up to date with the latest cannabis news, marijuana research, medical studies, legalization developments, industry trends, and scientific discoveries shaping the future of the plant. We cover important stories from across the cannabis world, including new research on THC and CBD, emerging medical applications, changes in marijuana laws and regulations, business and market developments, cultivation advances, and major findings from universities, researchers, and health organizations. Whether you are interested in cannabis science, medical marijuana, legalization, growing technology, or the evolving cannabis industry, our news coverage helps you understand the developments that matter and the research behind them.
LATEST CANNABIS NEWS
- House Set to Vote on Delaying Federal Hemp THC Ban as Congress Weighs New RegulationsCongress is approaching a consequential decision for the rapidly expanding hemp-derived cannabinoid industry. The U.S. House of Representatives is scheduled to consider H.R. 6500, the Continuing Appropriations and Extensions Act, 2027, a Senate-passed government funding measure that would postpone most of a sweeping new… Read more: House Set to Vote on Delaying Federal Hemp THC Ban as Congress Weighs New Regulations
- Federally Funded Study Finds Cancer Patients Report Pain, Sleep and Medication Benefits From Medical CannabisA newly published federally funded study is providing a more detailed picture of why people with cancer use medical cannabis and how the benefits they perceive may differ depending on whether their products contain cannabidiol alone or a combination of CBD and delta-9-tetrahydrocannabinol. Researchers… Read more: Federally Funded Study Finds Cancer Patients Report Pain, Sleep and Medication Benefits From Medical Cannabis
- DEA Begins Detailed Inspections of Medical Marijuana Businesses Under New Schedule III FrameworkThe federal government’s new approach to medical marijuana is moving from regulatory language to dispensary floors. The Drug Enforcement Administration has begun conducting detailed inspections of state-licensed medical cannabis businesses seeking federal registration under the Schedule III framework established earlier this year, and newly… Read more: DEA Begins Detailed Inspections of Medical Marijuana Businesses Under New Schedule III Framework
- CBD-Dominant Cannabis Oil May Reduce Chronic Pain After Knee Replacement, New Randomized Trial FindsA new randomized controlled trial from Canadian researchers is offering an intriguing signal that a CBD-dominant cannabis oil taken before and after total knee replacement may reduce the likelihood of developing chronic postsurgical pain. The multicenter pilot study, published August 25, 2026 in the… Read more: CBD-Dominant Cannabis Oil May Reduce Chronic Pain After Knee Replacement, New Randomized Trial Finds
- CBD May Increase THC Levels in the Body, Major Meta-Analysis FindsA major new analysis of controlled human cannabis studies is challenging one of the most persistent assumptions surrounding cannabidiol: that adding CBD to THC will necessarily weaken THC’s effects. Researchers reviewing 14 clinical experiments found that co-administering CBD with the same dose of delta-9-tetrahydrocannabinol… Read more: CBD May Increase THC Levels in the Body, Major Meta-Analysis Finds
- CBD Reduces OCD Symptoms in Randomized Placebo-Controlled Clinical TrialA small randomized, placebo-controlled clinical trial has found that daily cannabidiol (CBD) was associated with a statistically significant reduction in symptoms among people with obsessive-compulsive disorder, adding new human evidence to the emerging study of cannabinoids and psychiatric conditions. The research, published in July… Read more: CBD Reduces OCD Symptoms in Randomized Placebo-Controlled Clinical Trial
- CBD Matches Codeine-Acetaminophen for Pain After Laser Eye Surgery in Randomized Clinical TrialA randomized clinical trial by University of Florida researchers has found that a low-THC, full-spectrum oral cannabidiol preparation provided postoperative pain control comparable to codeine plus acetaminophen following photorefractive keratectomy, or PRK, a laser eye procedure known for producing several days of significant corneal… Read more: CBD Matches Codeine-Acetaminophen for Pain After Laser Eye Surgery in Randomized Clinical Trial
- Inhaled Cannabis Linked to Fewer Premature Heartbeats in Surprising Randomized Heart StudyA new randomized clinical trial is challenging some assumptions about the immediate cardiovascular effects of cannabis. Researchers led by the University of California, San Francisco found that habitual cannabis users experienced approximately 9 percent fewer premature heartbeats on days when they inhaled cannabis than… Read more: Inhaled Cannabis Linked to Fewer Premature Heartbeats in Surprising Randomized Heart Study
- Cannabis-Derived NTI164 Improves Autism Symptoms in Randomized Pediatric TrialA new randomized clinical trial is adding significant evidence to the debate over whether carefully standardized cannabis-derived medicines may have a role in treating symptoms associated with autism spectrum disorder. Published in Neurotherapeutics, the Phase II/III Harmony Study tested NTI164, a low-THC, full-spectrum medicinal… Read more: Cannabis-Derived NTI164 Improves Autism Symptoms in Randomized Pediatric Trial
- FDA Grants Breakthrough Therapy Status to Cannabis-Derived VER-01 for Chronic Back PainA cannabis-derived medicine for chronic low back pain has moved closer to a possible U.S. regulatory pathway after the Food and Drug Administration granted Breakthrough Therapy Designation to VER-01, an investigational full-spectrum Cannabis sativa extract developed by German pharmaceutical company Vertanical. The designation, announced… Read more: FDA Grants Breakthrough Therapy Status to Cannabis-Derived VER-01 for Chronic Back Pain
MARIJUANA NEWS ARCHIVES
- House Set to Vote on Delaying Federal Hemp THC Ban as Congress Weighs New Regulations
- Federally Funded Study Finds Cancer Patients Report Pain, Sleep and Medication Benefits From Medical Cannabis
- DEA Begins Detailed Inspections of Medical Marijuana Businesses Under New Schedule III Framework
- CBD-Dominant Cannabis Oil May Reduce Chronic Pain After Knee Replacement, New Randomized Trial Finds
- CBD May Increase THC Levels in the Body, Major Meta-Analysis Finds
- CBD Reduces OCD Symptoms in Randomized Placebo-Controlled Clinical Trial
- CBD Matches Codeine-Acetaminophen for Pain After Laser Eye Surgery in Randomized Clinical Trial
- Inhaled Cannabis Linked to Fewer Premature Heartbeats in Surprising Randomized Heart Study
- Cannabis-Derived NTI164 Improves Autism Symptoms in Randomized Pediatric Trial
- FDA Grants Breakthrough Therapy Status to Cannabis-Derived VER-01 for Chronic Back Pain
- WNBA Removes Marijuana From Banned Substances List Under New CBA
- House-Approved Funding Bill Would Allow VA Doctors to Recommend Medical Cannabis to Veterans
- Cannabis Drug Companies Eye IPOs as U.S. Reclassification Fuels Investor Surge
- Scientists Discover Rare Flavoalkaloids with Medical Potential in Cannabis Leaves
- DOJ Moves to Reschedule Medical Cannabis to Schedule III, Triggering Major Regulatory Shift
- Trump Signs Executive Order to Fast-Track Psychedelic Research for Mental Health Treatment
- Alabama Prepares to Open Its First Medical Cannabis Dispensary Next Month
- Federally Funded Study Unveils Marijuana Breathalyzer Breakthrough Using 3D-Printed Roadside Device
- The CLIMB Act: A Bipartisan Push to Unlock Capital for the U.S. Cannabis Industry
- Texas Ban on Selling Smokable Cannabis Takes Effect March 31










